Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)

Saved in:
Bibliographic Details
Main Authors: J. Van Wyk (Author), F. Ajana (Author), F. Bisshop (Author), S. De Wit (Author), Y. Osiyemi (Author), J. Portilla (Author), J. Routy (Author), C. Wyen (Author), M. Ait-Khaled (Author), M. Nascimento (Author), K. Pappa (Author), R. Wang (Author), J. Wright (Author), A. Tenorio (Author), B. Wynne (Author), M. Aboud (Author), M. Gartland (Author), K. Smith (Author), Y. El-Bahy (Author)
Format: Book
Published: Elsevier, 2020-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items